Liver disease (hepatitis, cirrhosis) — all decisions

The Board denied service connection for the cause of the Veteran's death, finding that none of his service-connected disabilities caused or contributed to his cardiac arrest and cirrhosis of the liver.

The Veteran withdrew his appeal regarding the claim for a compensable rating for service-connected hepatitis C, and the issue of entitlement to a total disability rating for individual unemployability (TDIU) due to service-connected disabilities remains under review.

The Board granted service connection for GERD but denied it for Hepatitis C and sleep apnea.

The Board denied the veteran's claims for service connection for hepatitis C, an increased rating for a low back condition, and eligibility for financial assistance in the purchase of an automobile or other conveyance. The claim for a temporary total evaluation was also denied.

The previously denied claim of entitlement to service connection for hepatitis C is reopened and granted in part, while other claims are remanded.

The Board granted service connection for type II diabetes mellitus and peripheral neuropathy of the upper and lower extremities, but remanded claims for erectile dysfunction, diverticulitis, a visual disorder, liver disorder, and gout.

The Board granted service connection for cirrhosis of the liver and hypertension, finding that both conditions are related to the Veteran's active military service.

The Board remands the veteran's claims for service connection for various conditions, including hepatitis C, hypertension, fatigue, muscle condition, diverticulitis, cognition condition, acquired psychiatric disorder, and obstructive sleep apnea, for further development.

The Board remands the claims for service connection for hypertension and hepatitis B for additional development, including obtaining new VA opinions.

The Board denied service connection for the Veteran's cause of death, finding no evidence that the conditions listed on his death certificate were related to his military service or exposure to herbicide agents.

The Board granted service connection for intra-abdominal adhesions and hepatitis B, while denying service connection for disseminated intravascular coagulation, esophagitis, gastritis, and osteopenia. The remaining issues were remanded.

The Board granted service connection for tinnitus and denied it for hepatitis C.

The Board denied service connection for cirrhosis of the liver, residuals of a liver transplant, and hepatitis C as these conditions were not shown to be related to the Veteran's military service.

The Board granted an earlier effective date of October 10, 2011, for the grant of a 50 percent rating for bilateral pes planus.

The Board granted restoration of a 20 percent rating for degenerative arthritis of the right knee, from September 28, 2018, to August 5, 2023, and a separate 10 percent rating for right knee limitation of motion. It also granted a total disability rating based on individual unemployability due to the aggregate effect of the Veteran's service-connected disabilities, effective January 20, 2021.

The Board remands the Veteran's claims for a higher rating for hepatitis B, left knee total joint replacement, right knee total joint replacement, and left knee surgical scar to ensure that due process is followed and there is a complete record upon which to decide the Veteran's claims.

The Board remands the claim for service connection for hepatitis C to obtain a new medical opinion addressing in-service exposure to air gun inoculations.

The Veteran's tension headaches were granted a 30 percent rating prior to September 17, 2019. The claim for a higher rating for GAD and service connection for COM was denied. The TDIU claim was withdrawn.

The Board denied service connection for hepatitis C and cirrhosis of the liver, finding that there was no evidence linking these conditions to the Veteran's military service.

The Board granted service connection for tinnitus and Hepatitis C, and assigned a 10 percent rating for the residual scar from left spermatocelectomy and epididyoplasty effective August 30, 2011.